Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma.
Saved in:
| Title: | Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma. |
|---|---|
| Authors: | Haque W; Department of Radiation Oncology, Houston Methodist Hospital, 18400 Katy Freeway, Houston, TX, 77094, USA. waqarh786@gmail.com., Teh C; Department of Biology, University of Texas, Austin, TX, USA., Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, 18400 Katy Freeway, Houston, TX, 77094, USA., Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, 18400 Katy Freeway, Houston, TX, 77094, USA. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2022 Mar; Vol. 157 (1), pp. 137-146. Date of Electronic Publication: 2022 Feb 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7373 |
|---|---|
| DOI: | 10.1007/s11060-022-03955-3 |
